UPDATE: According to Dan Kurtz of MyKBO.com, Pill has reached an agreement with the KIA Tigers.
10:06 p.m. ET, Thursday: According to Andrew Baggarly of CSNBayArea.com, Giants first baseman/outfielder Brett Pill is in talks to play with the KIA Tigers of the Korea Baseball Organization.
Baggarly hears that the Giants already have a deal in place to sell his contract, so Pill is just working on the money involved. John Shea of the San Francisco Chronicle reported earlier this evening that the Giants were asking for as much as $1 million to sell his contract to a team in Japan or Korea.
Pill, 29, has had a few stints with the Giants over the past three seasons while compiling a .223/.279/.404 batting line in 259 plate appearances.
Update (12:58 AM ET): Per Henry Schulman of the San Francisco Chronicle, Samardzija has been diagnosed with a strained pectoral muscle. He’ll be shut down for a week. That’s good news for the Giants, considering the alternatives.
Giants starter Jeff Samardzija will undergo an MRI on his ailing right shoulder, according to NBC Sports Bay Area. The right-hander struggled in a minor league game on Wednesday, surrendering a pair of home runs and hitting a batter. Overall this spring, Samardzija has given up 15 runs (13 earned) on 17 hits (six homers) and seven walks with seven strikeouts in 11 innings.
This may mean Samardzija won’t be ready for the start of the regular season. Derek Holland would likely replace Samardzija in the rotation. Holland had been competing for the No. 5 spot in the Giants’ rotation.
Samardzija led the National League in losses last season with 15, also posting a 4.42 ERA with a 205/32 K/BB ratio in a league-high 207 2/3 innings. Since becoming a starter, Samardzija has been able to avoid injury, making 32 or 33 starts in each of the last five seasons.